Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Rowe

Showing results (381-390 of 504) with videos related to

Pageof 51
Sort By:
Cancers|February 15, 2022
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Franz-Xaver Weinzierl, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point <sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced MelanomaSteve Y Cho, Evan J Lipson, Hyung-Jun Im, et al.
Nuclear Medicine Communications|July 26, 2019
Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomographyRudolf A Werner, Constantin Lapa, Sara Sheikhbahaei, et al.
Frontiers in Oncology|December 2, 2022
Automated lesion detection of breast cancer in [<sup>18</sup>F] FDG PET/CT using a novel AI-Based workflowJeffrey P Leal, Steven P Rowe, Vered Stearns, et al.
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Journal for Immunotherapy of Cancer|October 4, 2023
Non-invasive PD-L1 quantification using [<sup>18</sup>F]DK222-PET imaging in cancer immunotherapyAkhilesh Mishra, Kuldeep Gupta, Dhiraj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2023
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial CarcinomaXiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Endocrine|September 13, 2018
Volumetric and texture analysis of pretherapeutic Rudolf A Werner, Ralph A Bundschuh, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|October 30, 2018
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT ImagingRudolf A Werner, Charles Marcus, Sara Sheikhbahaei, et al.
Pageof 51

Showing results (381-390 of 504) with videos related to

Sort By:
Pageof 51
Cancers|February 15, 2022
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Franz-Xaver Weinzierl, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point <sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced MelanomaSteve Y Cho, Evan J Lipson, Hyung-Jun Im, et al.
Nuclear Medicine Communications|July 26, 2019
Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomographyRudolf A Werner, Constantin Lapa, Sara Sheikhbahaei, et al.
Frontiers in Oncology|December 2, 2022
Automated lesion detection of breast cancer in [<sup>18</sup>F] FDG PET/CT using a novel AI-Based workflowJeffrey P Leal, Steven P Rowe, Vered Stearns, et al.
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Journal for Immunotherapy of Cancer|October 4, 2023
Non-invasive PD-L1 quantification using [<sup>18</sup>F]DK222-PET imaging in cancer immunotherapyAkhilesh Mishra, Kuldeep Gupta, Dhiraj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2023
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial CarcinomaXiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Endocrine|September 13, 2018
Volumetric and texture analysis of pretherapeutic Rudolf A Werner, Ralph A Bundschuh, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|October 30, 2018
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT ImagingRudolf A Werner, Charles Marcus, Sara Sheikhbahaei, et al.
Pageof 51